Novavax Inc (NVV1.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 08:52PM CEST. Market open.
| Previous close | 11.87 |
| Open | 12.40 |
| Bid | 11.74 x N/A |
| Ask | 11.79 x N/A |
| Day's range | 10.86 - 12.48 |
| 52-week range | 3.41 - 13.38 |
| Volume | |
| Avg. volume | 3,919 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
FX EmpireNovavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
The past five days have been a rollercoaster for Novavax investors, as the share price of the company skyrocketed by over 200% following the announcement of a major deal with French pharmaceutical giant Sanofi.
ZacksZacks Investment Ideas feature highlights: GameStop, AMC, Novavax, S&P 500 Index ETF and Nvidia
GameStop, AMC, Novavax, S&P 500 Index ETF and Nvidia have been highlighted in this Investment Ideas article.
Investor's Business DailyIs Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Novavax stock nearly tripled over two days in May after inking a commercialization deal with Sanofi. Is NVAX stock a buy right now?
© 2024 Yahoo. All rights reserved.